Welcome to LookChem.com Sign In|Join Free
  • or
(5-methyl-1,3,4-oxadiazol-2-yl)acetonitrile(SALTDATA: FREE) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

130781-63-4

Post Buying Request

130781-63-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

130781-63-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 130781-63-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,7,8 and 1 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 130781-63:
(8*1)+(7*3)+(6*0)+(5*7)+(4*8)+(3*1)+(2*6)+(1*3)=114
114 % 10 = 4
So 130781-63-4 is a valid CAS Registry Number.
InChI:InChI=1/C5H5N3O/c1-4-7-8-5(9-4)2-3-6/h2H2,1H3

130781-63-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(5-methyl-1,3,4-oxadiazol-2-yl)acetonitrile

1.2 Other means of identification

Product number -
Other names (5-Methyl-[1,3,4]oxadiazol-2-yl)-acetonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:130781-63-4 SDS

130781-63-4Downstream Products

130781-63-4Relevant academic research and scientific papers

THIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS CAUSED BY IGE

-

Page/Page column 233; 234, (2020/01/11)

Thiophene derivatives of formula (I) and a pharmaceutically acceptable salt thereof are provided. These compounds have utility for the treatment or prevention of disorders caused by IgE, such as allergy, type 1 hypersensitivity or familiar sinus inflammation.

HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK

-

Paragraph 0175, (2014/05/24)

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 130781-63-4